跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15,523 条关于
“Prime Eight Capital”
全部
15,523
临床试验
9,521
药物
127
机构
147
资讯
5,728
11个月前
Arthrosi Raises $153M to Advance Next-Generation Gout Therapy Through Phase III Trials
9个月前
Prime Medicine Reports First-in-Human Prime Editing Success for Chronic Granulomatous Disease in NEJM
去年
Prime Medicine Reports Breakthrough Clinical Data for First Prime Editing Therapy in Chronic Granulomatous Disease
2个月前
Florida Sues Prime Therapeutics and Express Scripts for Alleged Drug Price Fixing
2个月前
Prime Medicine Advances Toward Clinical Milestones Following Patent Dispute Resolution
3年前
EMA Grants PRIME Designation to mRNA-4157/V940 Plus Pembrolizumab for High-Risk Melanoma
去年
Faron Pharmaceuticals' Bexmarilimab Shows Promise in Myelodysplastic Syndrome Treatment
去年
Pentixapharm's Ga68-PentixaFor Receives EMA PRIME Status for Primary Aldosteronism Diagnosis
2个月前
LifeSci Capital Maintains Buy Rating on Tenax Therapeutics with $35 Price Target
去年
Nurix Therapeutics' NX-5948 Receives EMA PRIME Designation for Relapsed/Refractory CLL
第 1 页,共 573 页
上一页
下一页